NCCM
ISEE

Nine Chapters Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Nine Chapters Capital Management’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$38K Buy
13,500
+2,200
+19% +$5.94K 0.08% 144
2017
Q2 		$29K Buy
+11,300
New +$30.8K 0.27% 51
2015
Q4 		– Sell
-13,800
Closed -$559K – 630
2015
Q3 		$559K Sell
13,800
-9,900
-42% -$524K 0.05% 530
2015
Q2 		$1.23M Buy
23,700
+14,900
+169% +$741K 0.1% 285
2015
Q1 		$409K Buy
+8,800
New +$457K 0.03% 641

Other funds holding ISEE

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Nine Chapters Capital Management's ISEE Position: Q3 2017 in Review

Nine Chapters Capital Management increased its IVERIC bio, Inc. Common Stock (ISEE) stake by 19% in Q3 2017, buying an estimated $5.94K and bringing the position to 13,500 shares worth $38K. The position accounts for 0.08% of the portfolio, ranked #144.

Nine Chapters Capital Management first reported a position in ISEE in Q1 2015 and has held it in 5 quarters since. The position peaked at $1.23M in Q2 2015. 67 funds tracked by Wall St. Rank hold ISEE as of Q3 2017.

  • Nine Chapters Capital Management held 13,500 shares of IVERIC bio, Inc. Common Stock worth $38K as of Q3 2017.
  • Nine Chapters Capital Management bought 2,200 IVERIC bio, Inc. Common Stock shares in Q3 2017, an estimated $5.94K.
  • IVERIC bio, Inc. Common Stock made up 0.08% of Nine Chapters Capital Management's portfolio in Q3 2017, its #144 holding.
  • Nine Chapters Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q1 2015 and has held it in 5 quarters since.
  • Nine Chapters Capital Management's IVERIC bio, Inc. Common Stock position peaked at $1.23M in Q2 2015.
  • 67 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2017.

Based on Nine Chapters Capital Management's 13F filing for Q3 2017, filed 31 Oct 2017.